Abstract: The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an interferon-based therapeutic agent, and ii) administering an additional anticancer agent, preferably, Gemcitabine, to a subject, wherein said additional anti-cancer agent is administered after the first administration of said intermittent administration of an interferon-based therapeutic agent. The present invention also relates to a pharmaceutical combination for use in said method.

Abstract: The present invention is a method for enabling virtual reality interaction with gesture control, comprising the following steps: displaying a photographed second image in response to a gesture detecting signal; recognizing an actual gesture action in the second image and converting the same into a graphic pointer; and displaying a first image and displaying the graphic pointer at a position corresponding to the first image for interaction. A user may conduct control directly with a gesture to enable virtual reality, thereby solving the problem where the user cannot see an actual scenario as well as increasing the ease of use for virtual reality.

Abstract: The present invention is a method for enabling virtual reality interaction with gesture control, comprising the following steps: displaying a photographed second image in response to a gesture detecting signal; recognizing an actual gesture action in the second image and converting the same into a graphic pointer; and displaying a first image and displaying the graphic pointer at a position corresponding to the first image for interaction. A user may conduct control directly with a gesture to enable virtual reality, thereby solving the problem where the user cannot see an actual scenario as well as increasing the ease of use for virtual reality.